about
Glutamate, T cells and multiple sclerosis.Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole.Autocrine glutamatergic transmission for the regulation of embryonal carcinoma stem cells.Paving the Way to Understand Autoantibody-Mediated Epilepsy on the Molecular Level.Extracellular vesicles are independent metabolic units with asparaginase activity.Frontline Science: c-Myc regulates P-selectin glycoprotein ligand-1 expression in monocytes during HIV-1 infection.Glutamate dependent NMDA receptor 2D is a novel angiogenic tumour endothelial marker in colorectal cancer.An iGlu receptor antagonist and its simultaneous use with an anticancer drug for cancer therapy.NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment.The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages.Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer.Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors.Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players.Effects of hypoxic preconditioning on neuroblastoma tumour oxygenation and metabolic signature in a chick embryo model
P2860
Q31165986-0E87884D-E867-471E-9606-047E66FF82BBQ36288488-042CDE09-2822-4DC1-B2A7-5EB1CF462F2FQ37580275-8107E91F-9A9B-4647-B7C4-DAAC666BF4FAQ38555932-D2208736-E26E-465A-8F3F-B424CD5A2B91Q38696824-463C3B28-070C-40A8-97CE-BD2D3429CCB1Q38701621-30E1CCC8-15CF-461F-86D0-6EFA766D31B9Q38899910-49A3CE20-9E36-4077-A885-7C044501ADBFQ38904231-E7855031-F083-4B2B-B1AA-E0E34710E37FQ41096139-54D08AB0-B145-4439-8076-51152B0A4EA9Q41696512-BEBCCEFC-2FCD-45BB-8B47-6527AF95495FQ41851711-62D4AB45-133E-4C63-90DC-930C1D7BE113Q42367899-628FCCE3-09E2-49B3-B292-06322A8E0631Q47125672-D8999BD9-C982-4D99-B93E-00512928CF8FQ52998486-D259FCAA-D18C-42CA-B5CE-00751FFEC13EQ54957053-8471DB3E-615D-4572-B7AF-57DB3561FA9BQ55425154-4155CA02-74AF-4EF0-B7E9-165DF4389B8FQ58693560-864BBA84-4AC9-4C2E-A78F-A1E8148E9946
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Glutamate and its receptors in cancer
@ast
Glutamate and its receptors in cancer
@en
Glutamate and its receptors in cancer
@nl
type
label
Glutamate and its receptors in cancer
@ast
Glutamate and its receptors in cancer
@en
Glutamate and its receptors in cancer
@nl
prefLabel
Glutamate and its receptors in cancer
@ast
Glutamate and its receptors in cancer
@en
Glutamate and its receptors in cancer
@nl
P2860
P921
P1476
Glutamate and its receptors in cancer
@en
P2093
Chrysanthy Ikonomidou
Krzysztof Polberg
P2860
P2888
P304
P356
10.1007/S00702-014-1182-6
P577
2014-03-09T00:00:00Z